Zobrazeno 1 - 10 of 69 pro vyhledávání: '"Zaman GJ"'
2
Akademický článek
IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
Autor: Li Y; Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands., Buijs-Gladdines JG; Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Canté-Barrett K; Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Stubbs AP; Department of Bioinformatics, Erasmus Medical Center, Rotterdam, The Netherlands., Vroegindeweij EM; Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Smits WK; Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Marion R; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands., Dinjens WN; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands., Horstmann M; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Co-operative Study Group for Childhood Acute Lymphoblastic Leukemia, Hamburg, Germany., Kuiper RP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Buijsman RC; Netherlands Translational Research Center, Oss, The Netherlands., Zaman GJ; Netherlands Translational Research Center, Oss, The Netherlands., van der Spek PJ; Department of Bioinformatics, Erasmus Medical Center, Rotterdam, The Netherlands., Pieters R; Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Meijerink JP; Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Publikováno v: PLoS medicine [PLoS Med] 2016 Dec 20; Vol. 13 (12), pp. e1002200. Date of Electronic Publication: 2016 Dec 20 (Print Publication: 2016).
Zobrazit plný text záznamu
3
Akademický článek
Cell Panel Profiling Reveals Conserved Therapeutic Clusters and Differentiates the Mechanism of Action of Different PI3K/mTOR, Aurora Kinase and EZH2 Inhibitors.
Autor: Uitdehaag JC; Netherlands Translational Research Center B.V., Kloosterstraat, the Netherlands., de Roos JA; Netherlands Translational Research Center B.V., Kloosterstraat, the Netherlands., Prinsen MB; Netherlands Translational Research Center B.V., Kloosterstraat, the Netherlands., Willemsen-Seegers N; Netherlands Translational Research Center B.V., Kloosterstraat, the Netherlands., de Vetter JR; Netherlands Translational Research Center B.V., Kloosterstraat, the Netherlands., Dylus J; Netherlands Translational Research Center B.V., Kloosterstraat, the Netherlands., van Doornmalen AM; Netherlands Translational Research Center B.V., Kloosterstraat, the Netherlands., Kooijman J; Netherlands Translational Research Center B.V., Kloosterstraat, the Netherlands., Sawa M; Carna Biosciences, Inc., Kobe, Japan., van Gerwen SJ; Netherlands Translational Research Center B.V., Kloosterstraat, the Netherlands., de Man J; Netherlands Translational Research Center B.V., Kloosterstraat, the Netherlands., Buijsman RC; Netherlands Translational Research Center B.V., Kloosterstraat, the Netherlands., Zaman GJ; Netherlands Translational Research Center B.V., Kloosterstraat, the Netherlands. guido.zaman@ntrc.nl.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2016 Dec; Vol. 15 (12), pp. 3097-3109. Date of Electronic Publication: 2016 Sep 01.
Zobrazit plný text záznamu
4
Akademický článek
MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia.
Autor: Canté-Barrett K; Department of Pediatric Oncology/Hematology, Erasmus MC Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands., Spijkers-Hagelstein JA; Netherlands Translational Research Center B.V., Oss, The Netherlands., Buijs-Gladdines JG; Department of Pediatric Oncology/Hematology, Erasmus MC Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands., Uitdehaag JC; Netherlands Translational Research Center B.V., Oss, The Netherlands., Smits WK; Department of Pediatric Oncology/Hematology, Erasmus MC Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands., van der Zwet J; Department of Pediatric Oncology/Hematology, Erasmus MC Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands., Buijsman RC; Netherlands Translational Research Center B.V., Oss, The Netherlands., Zaman GJ; Netherlands Translational Research Center B.V., Oss, The Netherlands., Pieters R; The Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Meijerink JP; Department of Pediatric Oncology/Hematology, Erasmus MC Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands.
Publikováno v: Leukemia [Leukemia] 2016 Sep; Vol. 30 (9), pp. 1832-43. Date of Electronic Publication: 2016 Apr 22.
Zobrazit plný text záznamu
5
Akademický článek
Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model.
Autor: Maia AR; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam., de Man J; Netherlands Translational Research Center B.V., Oss., Boon U; Division of Molecular Pathology and Cancer Genomics Centre., Janssen A; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam., Song JY; Division of Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam., Omerzu M; Department of Medical Oncology., Sterrenburg JG; Netherlands Translational Research Center B.V., Oss., Prinsen MB; Netherlands Translational Research Center B.V., Oss., Willemsen-Seegers N; Netherlands Translational Research Center B.V., Oss., de Roos JA; Netherlands Translational Research Center B.V., Oss., van Doornmalen AM; Netherlands Translational Research Center B.V., Oss., Uitdehaag JC; Netherlands Translational Research Center B.V., Oss., Kops GJ; Department of Medical Oncology Department of Cancer Genomics Netherlands, UMC Utrecht, Utrecht, The Netherlands., Jonkers J; Division of Molecular Pathology and Cancer Genomics Centre Department of Cancer Genomics Netherlands, UMC Utrecht, Utrecht, The Netherlands., Buijsman RC; Netherlands Translational Research Center B.V., Oss., Zaman GJ; Netherlands Translational Research Center B.V., Oss guido.zaman@ntrc.nl., Medema RH; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam Department of Cancer Genomics Netherlands, UMC Utrecht, Utrecht, The Netherlands.
Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2015 Oct; Vol. 26 (10), pp. 2180-92. Date of Electronic Publication: 2015 Jul 07.
Zobrazit plný text záznamu
6
Akademický článek
Selective Targeting of CTNBB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs.
Autor: Uitdehaag JC; Netherlands Translational Research Center B.V., Oss, The Netherlands., de Roos JA; Netherlands Translational Research Center B.V., Oss, The Netherlands., van Doornmalen AM; Netherlands Translational Research Center B.V., Oss, The Netherlands., Prinsen MB; Netherlands Translational Research Center B.V., Oss, The Netherlands., Spijkers-Hagelstein JA; Netherlands Translational Research Center B.V., Oss, The Netherlands., de Vetter JR; Netherlands Translational Research Center B.V., Oss, The Netherlands., de Man J; Netherlands Translational Research Center B.V., Oss, The Netherlands., Buijsman RC; Netherlands Translational Research Center B.V., Oss, The Netherlands., Zaman GJ; Netherlands Translational Research Center B.V., Oss, The Netherlands.
Publikováno v: PloS one [PLoS One] 2015 May 27; Vol. 10 (5), pp. e0125021. Date of Electronic Publication: 2015 May 27 (Print Publication: 2015).
Zobrazit plný text záznamu
7
Akademický článek
Chromosomal instability, tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in human cells.
Autor: Kuznetsova AY; a Group Maintenance of Genome Stability ; Max Planck Institute of Biochemistry ; Martinsried , Germany., Seget K, Moeller GK, de Pagter MS, de Roos JA, Dürrbaum M, Kuffer C, Müller S, Zaman GJ, Kloosterman WP, Storchová Z
Publikováno v: Cell cycle (Georgetown, Tex.) [Cell Cycle] 2015; Vol. 14 (17), pp. 2810-20.
Zobrazit plný text záznamu
8
Akademický článek
High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes.
Autor: Seegers N; Netherlands Translational Research Center B.V., Oss, The Netherlands., van Doornmalen AM; Netherlands Translational Research Center B.V., Oss, The Netherlands., Uitdehaag JC; Netherlands Translational Research Center B.V., Oss, The Netherlands., de Man J; Netherlands Translational Research Center B.V., Oss, The Netherlands., Buijsman RC; Netherlands Translational Research Center B.V., Oss, The Netherlands., Zaman GJ; Netherlands Translational Research Center B.V., Oss, The Netherlands guido.zaman@ntrc.nl.
Publikováno v: Journal of biomolecular screening [J Biomol Screen] 2014 Oct; Vol. 19 (9), pp. 1266-74. Date of Electronic Publication: 2014 May 27.
Zobrazit plný text záznamu
9
Akademický článek
Controversies in ASSAY and drug development technologies: a focus on assessing irreproducibility.
Autor: Glickman JF; 1 The Rockefeller University , New York, New York., Lundbäck T, Napper AD, Niles WD, Simeonov A, Weaver CD, Yin HH, Zaman GJ, Osada H
Publikováno v: Assay and drug development technologies [Assay Drug Dev Technol] 2014 Oct; Vol. 12 (8), pp. 443-51.
Zobrazit plný text záznamu
10
Akademický článek
Comparison of the cancer gene targeting and biochemical selectivities of all targeted kinase inhibitors approved for clinical use.
Autor: Uitdehaag JC; Netherlands Translational Research Center B.V., Oss, The Netherlands., de Roos JA; Netherlands Translational Research Center B.V., Oss, The Netherlands., van Doornmalen AM; Netherlands Translational Research Center B.V., Oss, The Netherlands., Prinsen MB; Netherlands Translational Research Center B.V., Oss, The Netherlands., de Man J; Netherlands Translational Research Center B.V., Oss, The Netherlands., Tanizawa Y; Carna Biosciences Inc., Kobe, Japan., Kawase Y; Carna Biosciences Inc., Kobe, Japan., Yoshino K; Carna Biosciences Inc., Kobe, Japan., Buijsman RC; Netherlands Translational Research Center B.V., Oss, The Netherlands., Zaman GJ; Netherlands Translational Research Center B.V., Oss, The Netherlands.
Publikováno v: PloS one [PLoS One] 2014 Mar 20; Vol. 9 (3), pp. e92146. Date of Electronic Publication: 2014 Mar 20 (Print Publication: 2014).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje